- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
Established in 1994, the Center for Cancer and Blood Disorders at Children’s Hospital Colorado offers the region’s only dedicated pediatric bone marrow transplant (BMT) program. We performed more than 80 bone marrow transplants in 2016 for children, teens and young adults with hematologic, oncologic, immunologic and hereditary metabolic conditions.
The Bone Marrow Transplant program has been accredited by the Foundation for Accreditation of Cellular Therapy (FACT) since 2001. This certification is based on patient volumes, qualified staff, suitable facilities and having a comprehensive quality assurance program that meets current national FACT standards. This accreditation means our transplant team has been consistently recognized through national peer review for high-quality patient care and laboratory performance for bone marrow transplant. Children are in good hands at Children's Colorado. Our program is also an approved transplant site of the National Marrow Donor Program (NMDP), the Children’s Oncology Group (COG) and the Pediatric BMT Consortium.
Excellent bone marrow outcomes
Children’s Colorado is recognized as meeting the highest standards of 100-day and one-year post-BMT survival compared to other U.S. pediatric BMT programs by the International Bone Marrow Transplant Registry, the NMDP and U.S. News and World Report. See our BMT survival rates.
Optimal transplant care for teenagers and young adults
Research has shown that teens needing a bone marrow transplant do better when treated on pediatric protocols and in a pediatric setting.
Collaboration with referring providers
All team members are committed to providing excellent service to patients and providers through an efficient call-back and evaluation for urgent referrals. Streamlined communication also occurs before, during and after transplantation. Get more information for healthcare professionals.
Our multidisciplinary program includes:
Support services for your family:
Innovation and research to advance pediatric bone marrow transplantation
Members of the team are actively involved in pediatric bone marrow transplant research with the goal of improving BMT outcomes in children. Our team performed its first cord blood transplant in 1996, early in the investigation of this now common stem cell source. Today, we continue to have ongoing research projects that focus on optimizing the success of BMT for many pediatric disorders.
Read about Dr. Verneris' research on using immunity to cure cancer.
Hematology/Oncology - Pediatric , Pediatrics